Literature DB >> 15705275

Sexual orientation, use of drugs and risk perception among HIV-positive men in Sao Paulo, Brazil.

E M V Filipe1, E Batistella, A Pine, N J S Santos, V Paiva, A Segurado, N Hearst.   

Abstract

The aim of this cross-sectional study, carried out among 250 HIV-positive (HIV+) men who have sex with women, was to describe their risk perception before learning of their HIV+ status and their sexual and drug use behaviour. Of the 250 men, 62.0% were heterosexuals and 38.0% where bisexuals. They most often reported becoming infected through unprotected sex (24.5%) and injecting drug use (11.0%). They were usually tested because they became ill (42.2%). Condom use with women in all episodes of sexual intercourse before HIV+ diagnosis was reported by 22.6% of heterosexuals and 34.7% of bisexuals (P < 0.05). With respect to drug use, 58.0% reported the use of drugs at some period in their lifetime. A higher proportion of individuals who had used drugs perceived themselves at risk (P < 0.05). Findings showed that most HIV+ men who have sex with women, regardless of sexual orientation or injecting drug use, did not use condoms and did not perceive themselves at risk before learning of their HIV+ status, and only undergo testing due to illness. The implications for heterosexual transmission of HIV are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15705275     DOI: 10.1258/0956462052932764

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Barriers along the care cascade of HIV-infected men in a large urban center of Brazil.

Authors:  Michael Hoffmann; Sarah MacCarthy; Ashley Batson; Ann Crawford-Roberts; Jennifer Rasanathan; Amy Nunn; Luis Augusto Silva; Ines Dourado
Journal:  AIDS Care       Date:  2015-08-20

2.  What are the factors associated with HIV testing among male injecting and non-injecting drug users in Lashio, Myanmar: a cross-sectional study.

Authors:  Yu Mon Saw; Junko Yasuoka; Thu Nandar Saw; Krishna C Poudel; Soe Tun; Masamine Jimba
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.